bisantrene and Periphlebitis
bisantrene has been researched along with Periphlebitis in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cowan, JD; Osborne, CK; Sandbach, J; Von Hoff, DD | 1 |
| Kovach, JS; Powis, G | 1 |
| Blough, RR; Johnson, CM; Kilton, LJ; Muntean, B; Stiff, PJ; Sweet, D | 1 |
| Bishop, J; Coates, AS; Mann, GJ; Raghavan, D | 1 |
| Cavalli, F; Clavel, M; Gerard, B; Rozencweig, M; ten Bokkel Huinink, W | 1 |
| Blackstein, ME; Evans, WK; Osoba, D; Shepherd, FA; Taylor, D | 1 |
Other Studies
6 other study(ies) available for bisantrene and Periphlebitis
| Article | Year |
|---|---|
Bisantrene, an active drug in patients with advanced breast cancer.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Nausea; Phlebitis | 1984 |
Disposition of bisantrene in humans and rabbits: evidence for intravascular deposition of drug as a cause of phlebitis.
Topics: Animals; Anthracenes; Colonic Neoplasms; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Phlebitis; Rabbits; Rectal Neoplasms; Urinary Bladder Neoplasms | 1983 |
Phase II trial of Bisantrene for metastatic melanoma: an Illinois cancer council study.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Illinois; Infusions, Intravenous; Leukopenia; Male; Melanoma; Middle Aged; Phlebitis; Survival Rate | 1991 |
Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene.
Topics: Aminoacridines; Amsacrine; Anthracenes; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Mitoxantrone; Phlebitis; Skin Neoplasms | 1986 |
Phase II evaluation of bisantrene in metastatic breast cancer.
Topics: Anthracenes; Breast Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Neoplasm Metastasis; Phlebitis | 1985 |
Phase II evaluation of bisantrene in patients with advanced renal cell carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Phlebitis | 1985 |